Načítá se...
Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
Antithrombin (AT) is known as an important physiological anticoagulant. AT inactivates thrombin and multiple other coagulation factors, thereby strongly inhibiting the over-activation of the coagulation system during disseminated vascular coagulation (DIC). AT also suppresses the pro-inflammatory re...
Uloženo v:
| Vydáno v: | J Intensive Care |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4336274/ https://ncbi.nlm.nih.gov/pubmed/25705422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-014-0051-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|